Antidepressant Long-Term Studies Prior To Approval Should Not Be Required, Cmte. Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Psychopharmacologic Drugs Advisory Committee finds that the agency’s proposed requirement for long-term data would delay drug marketing.